akhatri

MHRA Class 2 Medicines Notification: Lercanidipine HCl 20mg Tablets (Recordati Industria) Drug alert number: EL(25)A/17 Date issued: 17 April 2025 Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of [...]

The post MHRA Class 2 Medicines Recall: Lercanidipine HCl 20mg Tablets (Recordati Industria) appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK Drug alert number: EL(25)A/16 Date issued: 08 April 2025 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of [...]

The post MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status as complete pack sizes from April 2025: Cetraxal® 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Cetraxal® Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma [...]

The post Cetraxal® preparations – change to special container status from sub-pack to complete pack appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) Drug alert number: EL(25)A/12 Date issued: 31 March 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, [...]

The post MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Megestrol (Megace®) 160mg tablets MSN/2025/016 Tier 2 – medium impact Date of issue: 25/03/2025 Megestrol (Megace®) 160mg tablets are out of stock until mid-April 2025. Medroxyprogesterone (Provera®) 200mg and 400mg tablets remain available and can support an increase in demand. Medroxyprogesterone [...]

The post Medicine Supply Notification: Megestrol (Megace®) 160mg tablets appeared first on Community Pharmacy England.